EML4-ALK Variant 3a/b as a mechanism of osimertinib resistance in a patient with EGFR L858R positive NSCLC
Cancer Genetics(2024)
关键词
ALK rearrangement,Drug resistance,Non-small cell lung cancer,Osimertinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要